• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国同步双侧乳腺癌发病率的全国趋势。

National trends of synchronous bilateral breast cancer incidence in the United States.

机构信息

Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.

Breast Oncology Program, Dana Farber/Brigham and Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02115, USA.

出版信息

Breast Cancer Res Treat. 2019 Nov;178(1):161-167. doi: 10.1007/s10549-019-05363-0. Epub 2019 Jul 19.

DOI:10.1007/s10549-019-05363-0
PMID:31325072
Abstract

PURPOSE

Increase in breast cancer survivorship, advancements in diagnostic imaging and standardization of contralateral breast screening before breast cancer surgery have resulted in increased detection of contralateral breast cancer (CBC). The aim of this study was to assess national trends of synchronous bilateral breast cancer (sBBC) and metachronous bilateral breast cancer (mBBC) incidence in newly diagnosed breast cancer patients.

METHODS

The Surveillance, Epidemiology, and End Results (SEER) database (1973-2014) was used to identify 11,177 women diagnosed with CBC. CBC was classified as sBBC when primary breast cancer in both breasts is diagnosed in the same year, or as mBBC, when diagnosed more than one year from primary breast cancer. Temporal trends in sBBC incidence were then evaluated using the Cochran-Armitage test for trend.

RESULTS

Of the 11,177 women diagnosed with CBC, 4228 (38%) had sBBC and 6949 (62%) had mBBC. The incidence of sBBC increased significantly from 1.4% in 1975 to 2.9% in 2014 (p < 0.001). sBBC was more likely to be diagnosed as early stage in recent years (78% in 1975 vs. 90% in 2014 [p < 0.001]), and 69% of patients were treated with mastectomy in 2014.

CONCLUSION

The number of sBBC has increased, and contralateral tumors are more likely to be detected at an early stage with the first primary breast cancer. Despite the early stage findings, most were treated with mastectomy. Further studies are needed to define the best therapy for patients with contralateral disease and optimal surveillance and detection methods.

摘要

目的

乳腺癌生存人数的增加、诊断成像技术的进步以及乳腺癌手术前对对侧乳房筛查的标准化,导致对侧乳腺癌(CBC)的检出率增加。本研究旨在评估新诊断乳腺癌患者中同时性双侧乳腺癌(sBBC)和异时性双侧乳腺癌(mBBC)的发病趋势。

方法

利用监测、流行病学和最终结果(SEER)数据库(1973-2014 年),确定了 11177 例 CBC 患者。当双侧乳房的原发性乳腺癌在同一年被诊断时,将 CBC 归类为 sBBC;当原发性乳腺癌诊断超过一年时,将其归类为 mBBC。然后使用 Cochran-Armitage 趋势检验评估 sBBC 发病率的时间趋势。

结果

在 11177 例诊断为 CBC 的女性中,4228 例(38%)为 sBBC,6949 例(62%)为 mBBC。sBBC 的发病率从 1975 年的 1.4%显著增加到 2014 年的 2.9%(p<0.001)。近年来,sBBC 更有可能被诊断为早期阶段(1975 年为 78%,2014 年为 90%[p<0.001]),2014 年 69%的患者接受了乳房切除术。

结论

sBBC 的数量有所增加,并且随着第一个原发性乳腺癌的发生,对侧肿瘤更有可能被早期发现。尽管发现处于早期阶段,但大多数患者仍接受了乳房切除术。需要进一步研究以确定对侧疾病患者的最佳治疗方法以及最佳的监测和检测方法。

相似文献

1
National trends of synchronous bilateral breast cancer incidence in the United States.美国同步双侧乳腺癌发病率的全国趋势。
Breast Cancer Res Treat. 2019 Nov;178(1):161-167. doi: 10.1007/s10549-019-05363-0. Epub 2019 Jul 19.
2
Bilateral breast cancer, synchronous and metachronous; differences and outcome.双侧乳腺癌,同时性和异时性;差异与结局
Breast Cancer Res Treat. 2015 Sep;153(2):277-83. doi: 10.1007/s10549-015-3538-5. Epub 2015 Aug 13.
3
Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer.同步和异时双侧乳腺癌中分子亚型一致性与生存结局的关系。
Breast. 2021 Jun;57:71-79. doi: 10.1016/j.breast.2021.03.005. Epub 2021 Mar 20.
4
Racial and Ethnic Disparities in Synchronous and Metachronous Bilateral Breast Cancer.种族和民族差异与双侧乳腺癌同步和异时性。
J Racial Ethn Health Disparities. 2023 Jun;10(3):1035-1046. doi: 10.1007/s40615-022-01291-w. Epub 2022 Apr 6.
5
Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.双侧乳腺癌经多模态治疗后:亚洲人群临床结局的报告。
Clin Breast Cancer. 2018 Aug;18(4):e727-e737. doi: 10.1016/j.clbc.2017.11.003. Epub 2017 Nov 9.
6
A Retrospective Study on the Clinicopathologic Characteristics and Outcomes of 179 Cases of Synchronous and Metachronous Bilateral Breast Cancer in China.中国179例同时性和异时性双侧乳腺癌临床病理特征及预后的回顾性研究
Clin Breast Cancer. 2022 Apr;22(3):e341-e349. doi: 10.1016/j.clbc.2021.09.009. Epub 2021 Sep 29.
7
The prognosis of synchronous and metachronous bilateral breast cancer in Chinese patients.中国患者同步性和异时性双侧乳腺癌的预后
Tumour Biol. 2013 Apr;34(2):995-1004. doi: 10.1007/s13277-012-0636-4. Epub 2013 Jan 9.
8
Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016).中国双侧乳腺癌:一项 10 年单中心回顾性研究(2006-2016 年)。
Cancer Med. 2021 Sep;10(17):6089-6098. doi: 10.1002/cam4.4141. Epub 2021 Aug 4.
9
Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.老年原位导管癌女性患者术前乳腺磁共振成像与对侧乳腺癌的发生情况
Breast Cancer Res Treat. 2016 Jul;158(1):139-148. doi: 10.1007/s10549-016-3858-0. Epub 2016 Jun 10.
10
Efficacy of Breast Conservation Therapy in Early Stage Bilateral Breast Cancer.保乳治疗在早期双侧乳腺癌中的疗效
Breast J. 1999 Jan;5(1):36-41. doi: 10.1046/j.1524-4741.1999.005001036.x.

引用本文的文献

1
Double trouble, managing bilateral inflammatory breast cancer: a case report.双重难题:双侧炎性乳腺癌的管理——病例报告
Front Oncol. 2025 Aug 20;15:1595513. doi: 10.3389/fonc.2025.1595513. eCollection 2025.
2
Bilateral Primary Breast Cancer With Discordance in Molecular Subtypes: A Case Report.分子亚型不一致的双侧原发性乳腺癌:一例报告
Int J Breast Cancer. 2025 Jun 23;2025:9082803. doi: 10.1155/ijbc/9082803. eCollection 2025.
3
Trends and survival benefits of bilateral breast-conserving surgery in patients with metachronous bilateral breast cancer.
异时性双侧乳腺癌患者双侧保乳手术的趋势及生存获益
BMC Womens Health. 2025 Apr 2;25(1):152. doi: 10.1186/s12905-025-03685-4.
4
A Study on Synchronous Bilateral Breast Cancer Radiotherapy Based on an Accelerator Integrated with Optical Surface Monitoring System.基于集成光学表面监测系统的加速器的同步双侧乳腺癌放射治疗研究
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251322075. doi: 10.1177/15330338251322075.
5
A retrospective bilateral breast proton pencil beam scanning and photon volumetric arc therapy planning comparison.一项回顾性双侧乳腺质子笔形束扫描与光子容积弧形治疗计划的比较。
Ther Radiol Oncol. 2023 Dec 30;7. doi: 10.21037/tro-22-23. Epub 2023 Nov 3.
6
DLCNBC-SA: a model for assessing axillary lymph node metastasis status in early breast cancer patients.DLCNBC-SA:一种评估早期乳腺癌患者腋窝淋巴结转移状态的模型
Quant Imaging Med Surg. 2024 Aug 1;14(8):5831-5844. doi: 10.21037/qims-24-257. Epub 2024 Jul 26.
7
Patient-derived organoid elucidates the identical clonal origin of bilateral breast cancer with diverse molecular subtypes.患者来源的类器官揭示了具有不同分子亚型的双侧乳腺癌相同的克隆起源。
Front Oncol. 2024 May 10;14:1361603. doi: 10.3389/fonc.2024.1361603. eCollection 2024.
8
Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo.SIVA 是从克隆相关的双侧乳腺癌中鉴定出的候选转移基因,其突变可促进乳腺癌细胞在体外和体内的扩散。
PLoS One. 2024 May 9;19(5):e0302856. doi: 10.1371/journal.pone.0302856. eCollection 2024.
9
Dosimetric Comparison of Postmastectomy Radiotherapy Plans for Synchronous Bilateral Breast Cancer, Including Regional Lymph Node Irradiation.同步双侧乳腺癌保乳术后放疗计划的剂量学比较,包括区域淋巴结照射。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231214449. doi: 10.1177/15330338231214449.
10
Discordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancers.同步双侧和单侧多灶性乳腺癌中Oncotype DX评分的不一致性。
Breast Cancer Res Treat. 2024 Jan;203(1):73-83. doi: 10.1007/s10549-023-07119-3. Epub 2023 Sep 26.